MEDICAL BOARD

Gabriel N. Hortobagyi, M.D., F.A.C.P.

Gabriel N. Hortobagyi, MD, FACP is Professor of Medicine, Chairman of the Department of Breast Medical Oncology and Nellie B. Connally Chair in Breast Cancer at the University of Texas MD Anderson Cancer Center.  He also serves as Director of the Breast Cancer Research Program.

Dr. Hortobagyi is an internationally recognized expert on the use of systemic therapy for the treatment of breast cancer. He pioneered research proving the benefits of preoperative chemotherapy to reduce the size of large tumors. His current interests include molecular characterization of breast cancer, new drug development, molecularly targeted treatments, mechanisms of drug resistance and gene therapy in breast cancer.  

He is the immediate President of the American Society of Clinical Oncology (ASCO).  He chairs the Breast Committee of the Southwest Oncology Group as well as the Data and Safety Monitoring Committee of the National Surgical Adjuvant Breast and Bowel Project.

Dr. Hortobagyi is author, or co-author, of over 750 full-length publications about breast cancer research, and authored more than 11 books and more than 110 book chapters on this subject.
 
He has received worldwide honors for his efforts in breast cancer research. In 2001, President Jacques Chirac named him Chevalier of the Order of la Legion d'Honneur de France. In 2003, Dr. Hortobagyi received the Glen Robbins Award in Breast Cancer Research from the New York Cancer Society and the Metropolitan Breast Cancer Group, and the Bristol-Myers Squibb 2003 Horizon Scientific Award. The Mexican Society of Oncology named him the 2005 World Leader in Oncology.


Rick Michaelson, M.D.

Dr. Rick Michaelson is Chief Medical Officer for Oncology for the Saint Barnabas Health Care System.  As Chief Medical Officer for Oncology for the Cancer Center at Saint Barnabas in Livingston, N.J., he maintains a large medical oncology practice devoted to breast cancer. 
 
He received his medical degree from the University of Pennsylvania and completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York City. 
 
Dr. Michaelson has won awards from the American Cancer Society and Saint Barnabas Medical Center, and has been recognized in directories of top physicians published by New York and New Jersey magazines. 
 
He is recognized regionally as a leader in breast cancer care in the state of New Jersey and is a frequent participant in activities sponsored by such groups as the New Jersey Commission on Cancer Research, NBCC and SHARE.


Larry Norton, M.D.

Dr. Larry Norton is Deputy Physician-in-Chief and Director of Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center in New York City.  He also serves as Medical Director of MSK 64th Street, comprised of the Evelyn H. Lauder Breast Center and the Iris Cantor Diagnostic Center. He is the principal investigator of a Program Project Grant from the National Cancer Institute, which is aimed at better understanding breast cancer in the laboratory and in bringing these advances into clinical practice.

On a national level, Dr. Norton has served as Chair of the Breast Committee of the National Cancer Institute's Cancer and Leukemia Group B, and is President of the National Alliance of Breast Cancer Organizations (NABCO). He is past President of the American Society of Clinical Oncology, and was appointed by President Clinton to the National Cancer Advisory Board of the NCI.

After receiving his M.D. from the College of Physicians and Surgeons, Columbia University, he trained in Internal Medicine at the Albert Einstein College of Medicine. He then served as a Clinical Associate and Investigator at the NCI prior to joining the faculty of the Mount Sinai Medical Center in New York from 1977 to 1988. He is currently Professor of Medicine, Weill Medical College of Cornell University.


Ruth Oratz, M.D., F.A.C.P.

Ruth Oratz, M.D., F.A.C.P. is Associate Professor of Clinical Medicine at New York University School of Medicine.
 
She is the founder of The Women's Oncology & Wellness Practice in New York City where she specializes in treating women with breast cancer and other malignancies, as well as those at risk for cancer.
 
A fellow of the American College of Physicians, Dr. Oratz graduated magna cum laude from Radcliffe College/Harvard University and received her M.D. degree from the Albert Einstein College of Medicine. She then completed her post-doctoral training in internal medicine and medical oncology at the New York University School of Medicine in New York City.

Dr. Oratz has been active in clinical research and is widely published in her field. She is a member of the Breast Cancer Research Committee of US Oncology and also teaches medical humanities and bioethics at the New York University School of Medicine.

She is a medical consultant to CancerCare and also serves on several advisory boards, including Cancer and Careers and Sharsheret: Linking Young Jewish Women in Their Fight Against Breast Cancer. Dr. Oratz has been listed in Redbook Magazine's "The Best Doctors in America" and in New York Magazine's "The Best Doctors in NYC."


Eric Winer, M.D.

Dr. Eric P. Winer is Director of the Breast Oncology Center at the Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School. 

He received his MD from Yale University, followed by training in internal medicine and serving as chief resident at Yale-New Haven Hospital. He subsequently was a fellow in hematology-oncology at Duke University Medical Center and from 1989 to 1997 served on the Duke faculty, where he ultimately was co-director of the multidisciplinary breast program.  In 2007, Dr. Winer was named chief scientific advisor of Susan G. Komen for the Cure.

He is also the co-chair of the breast cancer committee in the Cancer and Leukemia Group B (CALGB) and has had wide-ranging experience in numerous national and international breast cancer initiatives.  Dr. Winer is the recipient of the Clair W. and Richard P. Morse Research Award 2002, and the Joseph Sokal Memorial Lecturer from Duke University 1999.